MELD Score: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk m (subpages, bold title) |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
The '''MELD score''' can help predict mortality in patients with [[cirrhosis]] and end-stage liver disease. An [http://www.unos.org/resources/MeldPeldCalculator.asp?index=98 online calculator] is available. | The '''MELD score''' can help predict mortality in patients with [[cirrhosis]] and end-stage liver disease. The equation is: | ||
An [http://www.unos.org/resources/MeldPeldCalculator.asp?index=98 online calculator] is available. | |||
:<math>\mbox{MELD}= 6.43 + 3.78 * \mbox{ln} \left({\mbox{bilirubin mg/dL}}\right) + 9.57 * \mbox{ln} \left({\mbox{creatinine mg/dl}}\right) + 11.2 * \mbox{ln} \left({\mbox{INR}}\right)</math> | |||
In interpeting the MELD Score in hospitalized patients, the 3 month mortality is:<ref name="pmid11172350">{{cite journal |author=Kamath PS, Wiesner RH, Malinchoc M, ''et al'' |title=A model to predict survival in patients with end-stage liver disease |journal=Hepatology |volume=33 |issue=2 |pages=464–70 |year=2001 |pmid=11172350 |doi=10.1053/jhep.2001.22172}}</ref> | In interpeting the MELD Score in hospitalized patients, the 3 month mortality is:<ref name="pmid11172350">{{cite journal |author=Kamath PS, Wiesner RH, Malinchoc M, ''et al'' |title=A model to predict survival in patients with end-stage liver disease |journal=Hepatology |volume=33 |issue=2 |pages=464–70 |year=2001 |pmid=11172350 |doi=10.1053/jhep.2001.22172}}</ref> | ||
Revision as of 11:20, 19 May 2008
The MELD score can help predict mortality in patients with cirrhosis and end-stage liver disease. The equation is:
An online calculator is available.
In interpeting the MELD Score in hospitalized patients, the 3 month mortality is:[1]
- 40 or more - 100% mortality
- 30-39 - 83% mortality
- 20-29 - 76% mortality
- 10-19 - 27% mortality
- <10 - 4% mortality
The MELD has also been studied in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS).[2]
References
- ↑ Kamath PS, Wiesner RH, Malinchoc M, et al (2001). "A model to predict survival in patients with end-stage liver disease". Hepatology 33 (2): 464–70. DOI:10.1053/jhep.2001.22172. PMID 11172350. Research Blogging.
- ↑ Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000). "A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts". Hepatology 31 (4): 864–71. DOI:10.1053/he.2000.5852. PMID 10733541. Research Blogging.